Nathan Hanan
Nathan holds a bachelor’s degree in chemistry, biochemistry and molecular biophysics from the U of A, a master’s degree in clinical research from UCSD, a PharmD degree from the U of A, and completed a two-year NIH T32 postdoctoral fellowship in pediatric clinical pharmacology at UCSD where he developed PK/PD models using population methods to optimize dosing of antiretrovirals for the prophylaxis and treatment of neonates. Following his postdoctoral training, he worked as a pharmacometrician at Nektar Therapeutics where he led modeling and simulation efforts to support phase I/II clinical trials for immuno-oncology drug candidates.
